According to a recent study titled ‘Peptide Based Cancer Therapeutics Market Share, Size, Trends, Industry Analysis Report, By Drug Type; By Mode of Mechanism, By Distribution Channel, By Regions; Segment Forecast, 2020 -2027’, available with Market Study Report, global peptide based cancer therapeutics market size is projected to surpass a valuation of USD 17.18 billion by the end of the forecast period 2020-2027.
 

Growing prevalence of cancer in tandem with increasing number of screening programs in emerging nations are augmenting global peptide based cancer therapeutics market growth. In fact, NCA (National Cancer Center) claims that approximately 1,010, 200 cancer cases were recorded in 2016 in the U.S., out of which 576,100 were male patients while 434,100 were women. The death toll reached 374,000 in the nation the same year, majority of which were associated with colorectal cancer. In addition, high specificity of peptide based cancer vaccines is positively impacting the industry outlook, cites the study.
 

Request sample copy of this Report: https://www.marketstudyreport.com/request-a-sample/2963822/
 

For the uninitiated, peptides are compounds formed from artificial or natural biological linking of amino acid monomers. Apart from their wide use in treating various ailments, their precision based nature and targeting of solid tumor cells in the body renders them highly capable for fighting cancer. This had led to the rise of peptide based cancer therapeutics market. Moreover, peptide based cancer therapeutics have shown promising results in comparison to conventional cancer treatments.
 

Peptide based therapies in cancer treatment are mostly categorized as peptide conjugate nanomaterials, vaccines based on peptide, and pure play peptide therapy. These therapies offer various benefits over others such as low cost of peptides, easy administration, high specificity in targeting tumor cells, and less side effects in comparison drugs.
 

Major contenders influencing global peptide based cancer therapeutics market trends are Bausch Health Companies Inc. (formerly Valeant Pharmaceuticals), AbbVie, Inc., Johnson & Johnson, Amgen, Inc., Takeda Pharmaceutical Co., Ltd., Pfizer, Inc., Teva Pharmaceutical Industries Ltd., Allergan plc, Abbott, AstraZeneca plc.